Science News Roundup: Akcea Therapeutics genetic disease treatment gets FDA approval
Following is a summary of current science news briefs.
Akcea Therapeutics genetic disease treatment gets FDA approval
Akcea Therapeutics Inc said on Friday its treatment, developed along with Ionis Pharmaceuticals, which targets a rare genetic disease was approved by the U.S. Food and Drug Administration. Akcea's once-weekly injection, Tegsedi, treats hereditary ATTR amyloidosis patients with polyneuropathy.
(With inputs from agencies.)
Advertisement
ALSO READ
South Korea's Prime Minister and top officials step down following election loss
"We had belief and we won the game": GT opener Sai Sudarshan following last ball thriller against RR
"Team is giving 100 % in practice sessions": Darshan Nalkande following last-ball thriller against RR
Two senior Delhi government officials face FIR following Uttarakhand court order
Indian stock market will be volatile on Friday, following expectation of rate cut delay in US: Experts